SEC 13F Intelligence

Glenmede Trust Co Na / LLY

Glenmede Trust Co Na’s Eli Lilly & Co Position

Does Glenmede Trust Co Na own Eli Lilly & Co (LLY)? Yes — 306.8K shares worth $282M (+1.38% of its 13F portfolio) as of Q1 2026, down from 317.6K shares the prior filed quarter.

Position Value
$282M
Q1 2026
Shares
306.8K
% of Portfolio
+1.38%
Quarters Held
28
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $128MQ4 ’18Q1 ’19: $125MQ2 ’19: $98MQ3 ’19: $91MQ4 ’19: $68MQ4 ’19Q1 ’20: $68MQ2 ’20: $82MQ3 ’20: $73MQ4 ’20: $90MQ4 ’20Q1 ’21: $100MQ2 ’21: $117MQ3 ’21: $116MQ4 ’21: $136MQ4 ’21Q1 ’22: $129MQ2 ’22: $143MQ3 ’22: $147MQ4 ’22: $164MQ4 ’22Q1 ’23: $149MQ2 ’23: $149MQ3 ’23: $220MQ4 ’23: $230MQ4 ’23Q1 ’24: $286MQ2 ’24: $327MQ3 ’24: $316MQ4 ’24: $254MQ4 ’24Q1 ’25: $258MQ4 ’25: $341MQ1 ’26: $282Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026306.8K$282M+1.38%
Q4 2025317.6K$341M+1.62%
Q1 2025312.0K$258M+1.38%
Q4 2024328.9K$254M+1.30%
Q3 2024356.3K$316M+1.51%
Q2 2024361.6K$327M+1.66%
Q1 2024367.8K$286M+1.43%
Q4 2023394.8K$230M+1.19%
Q3 2023409.7K$220M+1.26%
Q2 2023434.4K$149M+0.85%
Q1 2023434.4K$149M+0.85%
Q4 2022448.9K$164M+0.96%
Q3 2022453.9K$147M+0.93%
Q2 2022441.6K$143M+0.84%
Q1 2022450.1K$129M+0.63%
Q4 2021493.5K$136M+0.65%
Q3 2021502.0K$116M+0.60%
Q2 2021510.2K$117M+0.61%
Q1 2021536.0K$100M+0.54%
Q4 2020534.2K$90M+0.50%
Q3 2020495.4K$73M+0.44%
Q2 2020501.9K$82M+0.50%
Q1 2020519.1K$68M+0.31%
Q4 2019519.1K$68M+0.31%
Q3 2019817.5K$91M+0.42%
Q2 2019886.7K$98M+0.43%
Q1 2019964.0K$125M+0.57%
Q4 20181.11M$128M+0.62%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Glenmede Trust Co Na’s full portfolio or all institutional holders of LLY.